

share
4-(2,3-Dimethyl-Benzyl)-1H-Imidazole CAS NO 76631-46-4
Unit Price:
CAS No.:76631-46-4
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
4-(2,3-Dimethyl-Benzyl)-1H-Imidazole is a specialized heterocyclic organic compound featuring a benzyl-substituted imidazole core. This structure makes it a valuable intermediate for synthesizing more complex molecules, particularly in the pharmaceutical and agrochemical sectors. It is primarily sought after by research institutions and industrial manufacturers involved in developing active pharmaceutical ingredients (APIs), catalysts, and advanced material precursors.
Application
- Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, particularly those targeting neurological or inflammatory pathways.
- Agrochemical Synthesis: Used in the research and production of advanced pesticides, herbicides, and fungicides.
- Catalyst Ligand Precursor: Serves as a starting material for creating N-heterocyclic carbene (NHC) ligands used in organometallic catalysis.
- Chemical Research & Development: Employed in academic and industrial R&D for exploring new organic reactions and material properties.
- Fine Chemical Production: An intermediate in the manufacture of dyes, pigments, and other performance chemicals.
Basic Information
| Product Name | 4-(2,3-Dimethyl-Benzyl)-1H-Imidazole |
| CAS No. | 76631-46-4 |
| Molecular Formula | C12H14N2 |
| Molecular Weight | 186.25 g/mol |
| Synonyms | 1H-Imidazole, 4-[(2,3-dimethylphenyl)methyl]-; 4-(2,3-Dimethylbenzyl)imidazole; 4-(2,3-Dimethylbenzyl)-1H-imidazole; 2,3-Dimethylbenzylimidazole; 4-(2,3-Xylylmethyl)imidazole; 1H-Imidazole, 4-[(2,3-dimethylphenyl)methyl]- (9CI); 4-(2,3-DMB)Imidazole |
| EINECS | Contact for details |
Quality Control
Our 4-(2,3-Dimethyl-Benzyl)-1H-Imidazole is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets precise customer specifications. Certificates of Analysis (COA) documenting all critical parameters are provided with every shipment.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at room temperature (15-25°C). Keep away from strong oxidizing agents.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification (IR) | Conforms to structure |
| Purity (HPLC) | ≥ 98.0% |
| Melting Point | Contact for details |
| Loss on Drying | ≤ 0.5% |
| Residue on Ignition | ≤ 0.1% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Mucochloric Acid CAS NO 87-56-9


n-Vinyl-2-Pyrrolidone CAS NO 88-12-0


1,3-Dibromo-5,5-Dimethylhydantoin CAS NO 77-48-5


2,5-Dimethyl-1H-Pyrrole CAS NO 625-84-3


1-Ethyl-3-Methylimidazolium Chloride CAS NO 65039-09-0


3,5-Dimethylpyrazole CAS NO 67-51-6


Trimethallyl Isocyanurate CAS NO 6291-95-8


2-Methyl-4H-3,1-Benzoxazin-4-One CAS NO 525-76-8


1,4-Dioxene CAS NO 543-75-9


2-Mercaptonicotinic Acid CAS NO 38521-46-9


2,3-Dihydrobenzofuran CAS NO 496-16-2


3-(2-Methoxyphenyl)-2-Methylquinazolin-4(3H)-One CAS NO 4260-28-0


1,3-Thiazolidin-2-One CAS NO 2682-49-7


10H-Pyrido(3,2-B)(1,4)Benzothiazine CAS NO 261-96-1


1,2,4-Triazole CAS NO 288-88-0


1,3-Dimethyl-5-Pyrazolone CAS NO 2749-59-9


Dibenz-(B,F)-1,4-Oxazephine CAS NO 257-07-8


2-Chloropyrimidine CAS NO 1722-12-9


2,3,4,5-Tetrahydrobenzo[F][1,4]Oxazepine CAS NO 17775-01-8


Thiane CAS NO 1613-51-0
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






